HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Beauty Market News: China Cosmetics Regulations Modernized, Florida Stops Local Oxybenzone Bans, More

Executive Summary

L’Oreal acquires Thayers Natural Remedies; Unilever, L’Oreal remove ‘whitening,’ ‘fair’ from labels; China finalizes modernization of cosmetics regulations; and Florida governor signs law preventing local bans on oxybenzone.

You may also be interested in...



PCPC Expects Rapid-Fire Implementing Measures Following China’s CSAR Drop

China’s newly adopted Cosmetics Supervision and Administration Regulation could mean less animal testing and speedier approval of new ingredients, according to Francine Lamoriello of the Personal Care Products Council. Coming implementing regulations, standards and guidances should help to provide needed clarity, she says.

Black Lives Matter: Industry Responses, Backlashes, Product Withdrawals And Rehires

Some of the world’s biggest beauty and personal-care companies are struggling to slot themselves in the Black Lives Matter movement. Perhaps it’s best to lie low. Is that an option?

Cosmetics Industry Awaits ‘Critical’ Safety Assessment Clarification Under China’s New Framework Reg

The China State Council’s January approval of an overarching Cosmetics Supervision and Administration Regulation promises to bring about long-awaited reforms. But draft regulations targeted for release in coming months will be key to the implementation of CSAR provisions, the Personal Care Products Council says.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

LL1122113

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel